ConvaTec Group plc
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
ConvaTec Group plc - overview
Established
1978
Location
Reading, -, UK
Primary Industry
Medical Devices & Equipment
About
ConvaTec Group plc, based in the UK, specializes in advancing medical technologies and services to enhance patient care in chronic conditions and wound management. ConvaTec Group plc, founded in 1978 in Reading, UK, focuses on developing medical products for chronic care. The company has undergone strategic shifts, including a Private Placement/Follow on funding round of GBP 315. 00 mn, raising total funds of GBP 315.
00 mn. The CEO team includes Andreas Kuhn and Karim Bitar, overseeing operations across various global locations. ConvaTec Group is dedicated to providing advanced medical products aimed at improving the care of patients with chronic conditions. Their offerings encompass innovative wound care products, ostomy care solutions, and continence and critical care products.
These solutions address critical patient needs related to skin integrity and infection prevention, ensuring optimal patient comfort and healing outcomes. The company serves healthcare providers, hospitals, and patients across North America, Europe, Latin America, and Asia-Pacific. In 2024, ConvaTec Group reported a revenue of GBP 2. 29 bn and an EBITDA of GBP 545.
70 mn. The company's revenue is generated through direct sales and partnerships with healthcare providers, focusing on specialized medical products supplied to hospitals and clinics, as well as direct-to-consumer offerings. ConvaTec Group plans to introduce new products focused on advancing care solutions for patients in chronic settings. The company aims to expand its market presence in Asia-Pacific and Latin America by 2025.
The recent funding of GBP 315. 00 mn will be utilized to support these initiatives, enhancing product development and facilitating entry into new geographic markets.
Primary Industry
Medical Devices & Equipment
Sub Industries
Surgical Devices, Medical Equipment Distributors
Website
www.convatecgroup.com
Verticals
Manufacturing
Company Stage
Mature
Total Amount Raised
Subscriber access only
ConvaTec Group plc - deals
| Deals Type | Deal Status | Target (s) | Deal Date | Investor(s) | Seller(s) | Deal size (Mn) | Enterprise value (Mn) | Post-money valuation (Mn) | EBITDA multiple (x) | Revenue multiple (x) | Lead partner (s) |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Add-on, Trade Sale | Completed | Triad Life Sciences, Inc. | - | ||||||||
| Secondary Buyout | Completed | ConvaTec Group plc | - | ||||||||
| Private Placement/Follow on | Completed | ConvaTec Group plc | - | ||||||||
| Add-on, Trade Sale | Completed | Woodbury Health Products, Inc. | - | ||||||||
| Private Placement/Follow on | Completed | ConvaTec Group plc | - |
Displaying 1 - 5 of 15
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.